Use of NAC in Alleviation of Hangover Symptoms
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02541422 |
Recruitment Status :
Completed
First Posted : September 4, 2015
Results First Posted : May 30, 2018
Last Update Posted : May 30, 2018
|
Sponsor:
St. Luke's Hospital and Health Network, Pennsylvania
Information provided by (Responsible Party):
Holly Stankewicz, D.O., St. Luke's Hospital and Health Network, Pennsylvania
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Study Type | Interventional |
---|---|
Study Design | Allocation: Randomized; Intervention Model: Crossover Assignment; Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor); Primary Purpose: Prevention |
Condition |
Hangover Symptoms, NAC |
Interventions |
Dietary Supplement: N Acetyl Cysteine Other: placebo |
Enrollment | 62 |
Participant Flow
Recruitment Details | |
Pre-assignment Details | 62 people were enrolled however only 49 were included in the analysis due to not submitting their surveys or did not complete the first day of the study. |
Arm/Group Title | NAC First, Then Placebo | Placebo First Then NAC Group |
---|---|---|
![]() |
Patients receiving NAC after drinking to breathalyzer value 0.1 and then completed the survey in the morning after drinking and then at a later date returned and drank again to BrAC level of 0.1 and received placebo then again completed the survey in the morning | Patients receiving placebo after drinking to breathalyzer value 0.1 and then completed the survey in the morning after drinking and then at a later date returned and drank again to BrAC level of 0.1 and received NAC then again completed the survey in the morning |
Period Title: First Intervention | ||
Started | 23 | 26 |
Completed | 23 | 26 |
Not Completed | 0 | 0 |
Period Title: Second Intervention | ||
Started | 23 | 26 |
Completed | 23 | 26 |
Not Completed | 0 | 0 |
Baseline Characteristics
Arm/Group Title | All Study Participants | |
---|---|---|
![]() |
All study participants received the 2 interventions - NAC and placebo. The participants completed one intervention on one day and returned to complete the other intervention on a subsequent day. | |
Overall Number of Baseline Participants | 49 | |
![]() |
[Not Specified]
|
|
Age, Categorical
Measure Type: Count of Participants Unit of measure: Participants |
||
Number Analyzed | 49 participants | |
<=18 years |
0 0.0%
|
|
Between 18 and 65 years |
49 100.0%
|
|
>=65 years |
0 0.0%
|
|
Sex: Female, Male
Measure Type: Count of Participants Unit of measure: Participants |
||
Number Analyzed | 49 participants | |
Female |
18 36.7%
|
|
Male |
31 63.3%
|
|
Race and Ethnicity Not Collected
[1] Measure Type: Count of Participants Unit of measure: Participants |
||
Number Analyzed | 0 participants | |
[1]
Measure Analysis Population Description: Race and Ethnicity were not collected from any participant.
|
||
Region of Enrollment
Measure Type: Number Unit of measure: Participants |
||
United States | Number Analyzed | 49 participants |
49 |
Outcome Measures
Adverse Events
Limitations and Caveats
[Not Specified]
More Information
Results Point of Contact
Name/Title: | Holly Stankewicz, D.O. |
Organization: | St. Luke's University Health Network |
Phone: | 610-360-2725 |
EMail: | holly.stankewicz@gmail.com |
Publications of Results:
Responsible Party: | Holly Stankewicz, D.O., St. Luke's Hospital and Health Network, Pennsylvania |
ClinicalTrials.gov Identifier: | NCT02541422 |
Other Study ID Numbers: |
SLHN 2015-27 |
First Submitted: | September 1, 2015 |
First Posted: | September 4, 2015 |
Results First Submitted: | July 1, 2017 |
Results First Posted: | May 30, 2018 |
Last Update Posted: | May 30, 2018 |